溶瘤病毒
全身给药
癌症研究
体内
病毒
材料科学
肿瘤微环境
化学
溶癌病毒
医学
肿瘤细胞
生物
免疫学
生物技术
作者
Lili Huang,Xue Li,Jinfeng Zhang,Qian Ru Zhao,Ming Jing Zhang,An‐An Liu,Dai‐Wen Pang,Hai‐Yan Xie
出处
期刊:Nano Letters
[American Chemical Society]
日期:2019-10-18
卷期号:19 (11): 8002-8009
被引量:65
标识
DOI:10.1021/acs.nanolett.9b03193
摘要
Oncolytic adenovirus (OA) is an ideal candidate for clinical anticancer treatment, because it can specifically replicate in tumor cells with high titer. However, its systemic administration is still hindered, because of severely compromised antitumor efficacy. Herein, an engineered OA was innovatively developed by enwrapping OA with calcium and manganese carbonates (MnCaCs) biomineral shell, which could protect the virus from removal of the host immune system and prolong its in vivo circulation. Upon accumulating in tumor sites, MnCaCs readily dissolved under the acidic microenvironment, releasing Mn 2+ that could convert endogenous H 2 O 2 into oxygen (O 2 ) and then enhance the duplication ability of OA, thus significantly increased the antitumor efficacy. Meanwhile, Mn 2+ and the increased O 2 individually endowed the T1 modal magnetic resonance imaging (MRI) and photoacoustic imaging (PAI) feasibility, providing real-time monitoring information for the therapy. This versatile engineered OA demonstrated its promise for visible and efficient oncolytic virotherapy by systemic administration.
科研通智能强力驱动
Strongly Powered by AbleSci AI